We are live on ! Find out more
DIG

Dauntless Investment Group Portfolio holdings

AUM $151M
1-Year Est. Return 76.14%
This Fund
S&P 500
This Quarter Est. Return
+11.35%
1 Year Est. Return
+76.14%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$126M
AUM Growth
-$34M
Cap. Flow
-$32.3M
Cap. Flow %
-25.65%
Top 10 Hldgs %
77.96%
Holding
92
New
27
Increased
20
Reduced
15
Closed
26

Top Buys

Rank Stock Value
1
FEMY icon
Femasys
FEMY
+$3.18M
2
AGRO icon
Adecoagro
AGRO
+$1.34M
3
MPC icon
Marathon Petroleum
MPC
+$1.11M
4
AEON icon
AEON Biopharma
AEON
+$941K
5
CGTX icon
Cognition Therapeutics
CGTX
+$756K

Sector Composition

Rank Sector Weight
1 Healthcare 7.9%
2 Consumer Staples 4.25%
3 Financials 2.79%
4 Real Estate 2.12%
5 Energy 1.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XP icon
26
XP
XP
$8.77B
$764K 0.61%
46,696
+26,626
+133% +$469K
OKYO
27
OKYO Pharma
OKYO
$82.4M
$746K 0.59%
471,523
-1,950,525
-81% -$4.23M
VLO icon
28
Valero Energy
VLO
$87.1B
$679K 0.54%
4,172
-1,262
-23% -$214K
TLPH icon
29
Talphera
TLPH
$70.1M
$660K 0.52%
579,320
+479,320
+479% +$578K
CGTX icon
30
Cognition Therapeutics
CGTX
$94.9M
$629K 0.5%
+466,000
New +$756K
PROF
31
Profound Medical
PROF
$290M
$595K 0.47%
+75,577
New +$486K
ALB icon
32
Albemarle
ALB
$14B
$584K 0.46%
+4,132
New +$469K
KWEB icon
33
CALL
KraneShares CSI China Internet ETF
KWEB
$5.65B
$524K 0.42%
15,400
-5,300
-26% -$204K
UNCY icon
34
Unicycive Therapeutics
UNCY
$143M
$516K 0.41%
+89,415
New +$477K
INMB icon
35
INmune Bio
INMB
$50.5M
$476K 0.38%
+304,922
New +$544K
UTI icon
36
Universal Technical Institute
UTI
$2.33B
$468K 0.37%
+17,922
New +$507K
NWAX.U
37
New America Acquisition I Corp Units
NWAX.U
$438K 0.35%
+42,093
New +$437K
TVA
38
Texas Ventures Acquisition III Corp
TVA
$316M
$419K 0.33%
39,378
+21,562
+121% +$234K
BBJP icon
39
JPMorgan BetaBuilders Japan ETF
BBJP
$18.5B
$406K 0.32%
6,162
+4,512
+273% +$307K
ACIU icon
40
AC Immune
ACIU
$233M
$363K 0.29%
+115,677
New +$365K
PTCT icon
41
PTC Therapeutics
PTCT
$5.78B
$362K 0.29%
+4,762
New +$346K
NRDY icon
42
Nerdy
NRDY
$105M
$345K 0.27%
+332,141
New +$374K
ZURA icon
43
Zura Bio
ZURA
$536M
$320K 0.25%
+61,010
New +$241K
EWT icon
44
iShares MSCI Taiwan ETF
EWT
$10.6B
$312K 0.25%
4,905
+205
+4% +$13.2K
MUFG icon
45
Mitsubishi UFJ Financial
MUFG
$253B
$292K 0.23%
18,413
IOBT
46
DELISTED
IO Biotech
IOBT
$275K 0.22%
+451,641
New +$336K
ICCC icon
47
ImmuCell
ICCC
$97.3M
$244K 0.19%
39,633
-47,488
-55% -$280K
AEXA
48
American Exceptionalism Acquisition Corp
AEXA
$570M
$224K 0.18%
+19,704
New +$221K
STIM icon
49
Neuronetics
STIM
$164M
$222K 0.18%
+160,927
New +$337K
MLP icon
50
Maui Land & Pineapple Co
MLP
$343M
$135K 0.11%
7,982
+720
+10% +$11.6K

Similar funds

Dauntless Investment Group's Q4 2025 Portfolio in Review

As of Q4 2025, Dauntless Investment Group held 92 positions worth $126M, down 21% from $160M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Dauntless Investment Group withdrew a net $32.3M in Q4 2025, closing 26 positions and reducing 15 holdings. Its most notable exit was Lineage Cell Therapeutics, an estimated $2.73M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.9% of assets, down from 12% a quarter earlier, followed by Consumer Staples and Financials.

Against the trend, Dauntless Investment Group opened a new position in Adecoagro worth $1.35M.

  • Dauntless Investment Group's largest Q4 2025 buy was Adecoagro: 170,778 shares worth $1.35M.
  • Dauntless Investment Group added most to Femasys in Q4 2025, an estimated $3.18M increase.
  • Dauntless Investment Group's biggest Q4 2025 reduction was Agnico Eagle Mines, cutting an estimated $4.34M.
  • Dauntless Investment Group fully exited Lineage Cell Therapeutics in Q4 2025, selling an estimated $2.73M.
  • Dauntless Investment Group's ten largest holdings make up 78% of its $126M portfolio in Q4 2025.
  • Dauntless Investment Group opened 27 new positions and closed 26 in Q4 2025.
  • Dauntless Investment Group's portfolio value fell 21% quarter-over-quarter to $126M.

Based on Dauntless Investment Group's 13F filing for Q4 2025, filed 17 Feb 2026.